Reply to: Serum samples should not be used to access circulating matrix metalloproteinase-9 levels as a prognostic marker of disease

Serum samples should not be used to asse

Serum samples should not be used to assess circulating matrix metalloproteinase-9 levels as a prognostic marker of disease

✍ Jose E. Tanus-Santos; Raquel F. Gerlach 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 36 KB

Ruokolainen et al. 1 have suggested recently that pretreatment serum matrix metalloproteinase (MMP)-9 levels could be of prognostic value in patients with head and neck squamous cell carcinoma. In addition, they have found that patients with high serum levels of MMP-9 had a 2-fold risk of dying comp